GlobalData
GlobalData

shankar besta

  • Home
  • Author: shankar besta

ADHD field presents significant opportunity for drug developers in 7MM, says GlobalData

Stimulants, amphetamines, and methylphenidates are the first-line treatment for moderate to severe attention-deficit/hyperactivity disorder (ADHD) across the seven major markets (7MM*). Non-stimulants are mainly utilized as second-line therapies due to their lack of efficacy. However, stimulants are highly controlled substances, and prescriptions are often restricted to 30 days. This creates a demand for non-stimulants with […]
Read more

Indian whiskey gains global recognition to compete with major international brands, says GlobalData

Indian whiskey, long considered a rum-variant for being made with spirits fermented from molasses, is now witnessing a transformation on the world stage, ready to end the dominance of global Scotch brands, including Talisker and Glenlivet. A largely spirits-consuming nation unlike other beer-dominated Asian countries, India is fast becoming a major producer of single malt […]
Read more

National Birth Defects Awareness Month highlights need for increased congenital syphilis testing in US, says GlobalData

January is observed as National Birth Defects Awareness and Prevention Month annually to raise awareness about birth defects in the US. In November 2023, the Centers for Disease Control and Prevention (CDC) issued a statement drawing attention to the steeply escalating incidence of syphilis cases in newborns in the US, indicating a 10-fold increase in […]
Read more

Bitcoin ETF approval underscores maturation of cryptocurrency space, says GlobalData

In a groundbreaking move equipped to reshape the financial industry, the Securities and Exchange Commission (SEC) has officially approved the eagerly awaited Bitcoin Exchange-Traded Fund (ETF). This historic approval underscores the maturation of the cryptocurrency space and the increasing acknowledgment of its potential as a legitimate and viable asset class, says GlobalData, a leading data […]
Read more

Generative AI will go mainstream in 2024 driven by adoption of specialized custom models and multimodal tool experimentation, says GlobalData

Generative AI was a groundbreaking development last year, with the emergence of popular chatbots such as OpenAI’s ChatGPT and Google’s Bard taking the technology world by storm. However, using the large language models (LLMs) powering these chatbots has several disadvantages, hindering the adoption of the technology. For this reason, LLMs will be gradually replaced by […]
Read more

Carmot acquisition propels Roche to forefront of obesity drug leadership, finds GlobalData

In a significant move in December 2023, Roche completed the acquisition of the US-based company Carmot Therapeutics in a deal worth $2.9 billion. This strategic acquisition provides Roche access to Carmot’s portfolio, which notably includes three lead molecules, all GLP-1 analogues, currently in the advanced stages of clinical trials for obesity and type 2 diabetes. […]
Read more
1 89 90 91 92 93 136